Kellen J. Fitzpatrick

Predicting [177Lu]Lu-PSMA-617 SPECT/CT-based absorbed dose to whole-body tumor volume from pre-therapy [68Ga]Ga-PSMA-11 PET metrics and common blood biomarkers

It has been shown that absorbed dose (AD) to whole-body tumor volume (WBTV) from [ 177 Lu]Lu-PSMA-617 radiopharmaceutical therapy (RPT) correlates with treatment response. Pre-therapy estimation of AD to WBTV could therefore aid clinicians with patient selection and dosimetry-gui...